Technical Analysis for TGTX - TG Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 6.84 4.43% 0.29
TGTX closed up 4.43 percent on Friday, August 16, 2019, on 65 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Flat
See historical TGTX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -4.87%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.87%
Inside Day Range Contraction -4.87%
20 DMA Resistance Bearish -4.07%
Shooting Star Candlestick Bearish -4.07%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.07%
Doji - Bearish? Reversal -4.07%
Earnings Movers Other -4.07%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.87%
Earnings Movers Other -4.87%

Older signals for TGTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
TG Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The company is developing two advanced therapies targeting hematological malignancies. The TGTX-1101 (ublituximab) is a novel, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes, which is in clinical development for patients with relapsed and refractory non-Hodgkin's lymphoma. The TGR-1202 is an orally available PI3K delta inhibitor believed to be important in the proliferation and survival of B-lymphocytes. TG Therapeutics, Inc. is headquartered in New York, New York.
Biopharmaceutical Cancer Treatment Of Cancer Monoclonal Antibodies Lymphoma Antibody Drug Conjugates Hematological Malignancies Camidanlumab Tesirine Cd20
Is TGTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.9
52 Week Low 3.32
Average Volume 1,290,619
200-Day Moving Average 6.3244
50-Day Moving Average 7.5154
20-Day Moving Average 7.1315
10-Day Moving Average 6.853
Average True Range 0.3999
ADX 16.54
+DI 18.8864
-DI 27.4456
Chandelier Exit (Long, 3 ATRs ) 6.7903
Chandelier Exit (Short, 3 ATRs ) 7.4397
Upper Bollinger Band 7.8476
Lower Bollinger Band 6.4154
Percent B (%b) 0.3
BandWidth 20.082732
MACD Line -0.2234
MACD Signal Line -0.202
MACD Histogram -0.0213
Fundamentals Value
Market Cap 426.2 Million
Num Shares 62.3 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -3.51
Price-to-Sales 3189.49
Price-to-Book 6.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.37
Resistance 3 (R3) 7.33 7.12 7.28
Resistance 2 (R2) 7.12 6.99 7.14 7.25
Resistance 1 (R1) 6.98 6.90 7.05 7.02 7.22
Pivot Point 6.77 6.77 6.81 6.79 6.77
Support 1 (S1) 6.63 6.64 6.70 6.67 6.46
Support 2 (S2) 6.42 6.55 6.44 6.43
Support 3 (S3) 6.28 6.42 6.40
Support 4 (S4) 6.32